Dynapar AQ is a novel Diclofenac injection manufactured by the Aquatech Process, which provides the full dose of 75 mg. Diclofenac in just 1 ml. The Aquatech process provides high concentration solutions of injections in an aqueous solvent system, thereby, providing the dose in a smaller volume. The reduced volume of injection and the low viscosity of the solution in Dynapar AQ ensure that the injection is virtually painless. The multiple advantages of Dynapar AQ have been demonstrated through a number of clinical trials. No wonder, Dynapar AQ has won several awards and citations.
An array of cutting-edge
Offering a globally renowned product portfolio
Dynapar AQ (Aquatech Technology)
Dynapar QPS (Quick Penetrating Solution (QPS) Technology)
Dynapar QPS is the world’s first Transdermal preparation of Diclofenac, which provides excellent pain relief after topical application, by enhancing the penetration of Diclofenac through the skin. Dynapar QPS is backed by proof of concept pharmacokinetic studies as well as clinical trials. Since Dynapar QPS provides prompt pain relief upon being administered to any inflamed area (knee, back, elbow, neck, ankle, etc.), it minimizes or eliminates the patient’s requirement of oral pain killers. Dynapar QPS, therefore, brings a paradigm shift in the management of musculoskeletal pain.
Naso B12 (NASOMAX Technology)
NASOMAX technology is a proprietary nasal drug delivery technology for safe and effective systemic delivery of the drug molecule, through the nasal route. Methylcobalamin has very low solubility in water. To provide optimum therapeutic benefit by the nasal route, Methylcobalamin is dissolved at 500 mcg per 0.1ml concentration, in a solvent system consisting of safe, non-irritating co-solvent which enhances absorption of Methylcobalamin rapidly through the nasal membrane.
Phlebotroy QPS is a safe and effective alternative for the management of Infusion-related Thrombophlebitis. Phlebotroy uses Quick Penetrating Solution or (QPS). The Quick Penetrating Solution is a novel patented drug delivery platform which provides quick and comprehensive penetration of the drug through the skin. QPS Technology provides a unique base in which the drug is solubilised. The base gets absorbed into the skin & thereby, carries the drug through the barrier of the stratum corneum. The application of QPS technology in formulation of topical heparin helps achieve higher concentration at the site of Thrombophlebitis with minimal systemic exposure.
Troypofol is an emulsion injection of Propofol and is manufactured by Nanoemulsion Technology with ultramodern facility for emulsion products equipped with a high-speed homogenizer and fine control on globule size of emulsion. Troypofol Nanoemulsion Technology results in small, uniform and controlled globule size of Troypofol Nanoemulsion which provides better efficacy of Troypofol and less incidence of pain. The usual globule size of our emulsion is around 200 nm, but Nanoemulsion Technology converts the globule size to less than 200 nm making it nanomized.
Cyanide Antidot Kit
The Cyanide Antidot Kit is used for the treatment of cyanide poisoning. It uses a small inhaled dose of amyl nitrite followed by intravenous sodium nitrite. This converts a portion of the haemoglobin’s iron from ferrous iron to ferric iron, converting the hemoglobin into Methaemoglobin. Cyanide is more strongly drawn to Methaemoglobin than to the Cytochrome Oxidase of the cells, effectively pulling the cyanide off the cells and onto the Methaemoglobin. Once bound with the cyanide, the Methaemoglobin becomes Cyanmethaemoglobin. The next part of the cyanide antidote kit is Sodium Thiosulfate which is administered intravenously. The Sodium Thiosulfate and Cyanmethaemoglobin become Thiocyanate, releasing the haemoglobin and the kidneys excrete the Thiocyanate.
Xykaa Extend 1000 (Duo Phase Technology)
To provide therapeutically meaningful extended delivery of drugs, Troikaa has developed Duo Phase Technology. Through this technology, the drug dose is split judiciously into two components, where one part delivers the drug immediately and the other releases the drug in a sustained release pattern. Thus drug delivery is biphasic and ensures the requisite pharmacokinetic profile. Drugs developed using this technology are extended-release Paracetamol tablets of 650mg. and 1000mg. (Xykaa Extend). Products manufactured using Duo Phase Technology are presented in stylized tablets which graphically represent the biphasic drug delivery.
Trofentyl OTFC (Intra Oral drug delivery)
Intra oral drug delivery provides an excellent route of drug delivery into the systemic circulation. It has inherent advantages such as the prompt onset of action & predictable drug delivery. Trofentyl OTFC is a lozenge of Fentanyl Citrate for the treatment of breakthrough pain. As soon as the patient rolls the lozenge in his/her oral cavity, the drug released from the lozenge gets absorbed from the oral mucosa. The pain relief starts in about 10-12 minutes and lasts for 20-25 minutes. In the event the patient experiences any adverse effects, he/she can simply take the lozenge out and the effect will wear off in a few minutes.
Xykaa Rapid 500 (Decompaction Technology)
Decompaction Technology ensures quick decompaction of granules to micro-fine particles, resulting in faster absorption and a quicker onset of action. Products manufactured using this technology is very useful in those conditions where a rapid onset of action is desirable. Currently, the two products manufactured using this technology are Dynapar Tablets (Diclofenac + Paracetamol) & Xykaa Rapid (Paracetamol). When ingested, the active drug is ready for absorption in just 45 seconds and hence, provides assured relief in less than 20 minutes.
The Myonit Insta is a fast acting Nitrate with the onset of action in 114 seconds it dissolves immediately when kept under tongue & provides immediate relief from anginal pain. The Myonit Insta is packed in the amber glass bottle, thus ensures undiminished potency throughout its shelf life. Also, it is available in easy-to-carry patient-friendly pack.
LiquiCaps (Liquid-filled & sealed Hard Gelatin Capsules), the latest innovation in encapsulation technology, are being accepted as the next generation capsules. LiquiCaps are 2-piece hard capsules, filled with oily medicaments & sealed with a band.
The major benefits offered by LiquiCaps over soft gelatin capsules include lower microbial load in the thin gelatin shell of LiquiCaps, as compared to the heavy microbial burden in softgels.
What is more, LiquiCaps disintegrate much faster as compared to softgels & hence release the active ingredient promptly on ingestion.